Analyst Comparison Highlights Dividend and Volatility Differences Between ResMed and…
What happened
A report compared ResMed and Abbott Laboratories, noting both are large-cap healthcare companies. The comparison covered earnings, valuation, dividend history, and risk metrics. The report found that Abbott Laboratories has a higher dividend yield of 2.6% compared to ResMed’s 1.2%, and Abbott Laboratories has increased its dividend for 54 consecutive years, while ResMed has done so for 13 years.
From themarketsdaily.com
Why it matters
The comparison highlights differences in financial profiles, such as ResMed’s beta of 0.75 versus Abbott Laboratories’ beta of 0.59. The analysis suggests that Abbott Laboratories is a stronger dividend stock based on its yield and longer track record of dividend growth.
From themarketsdaily.com
Who's involved
- ResmedManufacturer of respiratory products compared in the financial analysis.
- Abbott LaboratoriesGlobal health care and medical device company compared in the financial analysis.
Keep exploring
The entities involved
-
Resmed
manufacturer of CPAP masks, machines and products that diagnose, treat or help manage respiratory conditions
-
Abbott Laboratories
American global health care and medical device products company
Related events
- Abbott Laboratories was featured as one of five stocks to watch on MarketBeat on May 26, 2026.
- AbbVie and Abbott Laboratories are large healthcare companies whose corporate histories are linked by a major split that occurred in 2013.
- Abbott Laboratories acquired Exact Sciences, a company specializing in cancer diagnostics, in a move that also involved competition in the medical device market.
- Abbott Laboratories and Medtronic plc operate within the healthcare device sector.